Mammoth Admin
Posted by Mammoth Admin
October 6, 2021

Mammoth Scientific Selects SS&C for Inaugural VC Fund

Innovative venture capital firm will leverage SS&C's fund administration services and Intralinks' InvestorVision for fund

Read More
Mammoth Admin
Posted by Mammoth Admin
August 31, 2021

MiRus Receives FDA 510(K) Clearance For The Lowest Profile and Best-in-class Expandable Lumbar Interbody

MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody.

Read More
Mammoth Admin
Posted by Mammoth Admin
August 25, 2021

U.S. Venture Capital Firm backs MRIguidance

Mammoth Scientific invests $1.25 Million in MRIguidance through its venture capital fund Mammoth Private Capital to enable further growth and prepare for market roll-out of BoneMRI in the U.S.

Read More
Mammoth Admin
Posted by Mammoth Admin
July 28, 2021

MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices

MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®). The round was led by Mammoth Scientific and multi-generational family offices who have supported MiRus from its inception.

Read More

  • Mammoth Scientific is a venture capital company that specializes in health science and technology funds.
  • OFFICE ADDRESS
    3201 Stellhorn Road, Suite A-124
    Fort Wayne, IN 46815
  • OFFICES

    Atlanta
    Charleston
    Charlotte
    Fort Wayne
    Metro Detroit
  • Disclaimer

    Mammoth Scientific, LLC, is an investment adviser to certain venture capital funds. Mammoth Scientific files as an exempt reporting adviser but that status does not imply a certain level of skill or training. Private companies and private investments involve unique risks including substantial risk of loss and are not suitable for all investors. Past performance should not be construed as an indicator of future success. Any offer of securities in the Mammoth Fund may only be made by delivery by Mammoth Scientific to the potential investor of formal offering documents. We do not provide personalized advice about investments. Mammoth Institutional Services provides private fund administration and investment technology services. Securities offered through The Securities Group, LLC dba Mammoth Research. Member FINRA/SIPC.

    The information provided on this mammoth.is website (“Site”) is provided to accredited and qualified investors to assist in evaluating investment opportunities. The Site itself and the content on the Site are not offering documents. Any offer of securities related to Mammoth Health and Tech Fund 1- Accredited, Mammoth Health and Tech Fund 1- Qualified or any of the Mammoth venture capital funds (“Mammoth Funds”) may only be made by Mammoth Scientific, LLC (“Mammoth Scientific”) as the Manager of the Mammoth Funds by delivery of definitive offering documents to the investor. Securities offered by Mammoth Scientific have not been registered under the Securities Act of 1933, as amended or the securities laws of any state or other jurisdictions in reliance upon exemptions from registration provided by the Securities Act and Regulation D Rule 506(c) and comparable exemptions.

    PRIVATE COMPANIES AND PRIVATE INVESTMENTS INVOLVE UNIQUE RISKS. YOU SHOULD BE AWARE THAT WHEN INVESTING IN PRIVATE INVESTMENTS, YOU COULD LOSE YOUR ENTIRE INVESTMENT. WE RECOMMEND INVESTORS ONLY INVEST FUNDS WHICH THEY HAVE THE FINANCIAL CAPACITY TO LOSE.

    The Securities Group LLC dba Mammoth Research (“TSG/Mammoth Research”), 3201 Stellhorn Road, Suite A-124, Fort Wayne, IN 46815, is a broker/dealer registered with the Securities and Exchange Commission (“SEC”) and a member of the Financial Industry Regulatory Authority (“FINRA”). In such capacity, TSG/Mammoth Research is the Managing Placing Agent for the Mammoth Funds. TSG/Mammoth Research and Mammoth Scientific share a common control person and are under common ownership as subsidiaries of Mammoth Investors, LLC.

    All product names, logos, and brands are property of their respective owners in the U.S. and other countries and are used for identification purposes only. Use of these names, logos, and brands does not imply affiliation or endorsement. All images shown are for illustration purposes only. Actual product may vary due to product enhancements.

© 2022, Mammoth Investors, LLC
All rights reserved.
We use cookies to give you the best experience.